Bibliography: Mare Cudic, Ph.D.
Design-functionality relationships for adhesion/growth-regulatory galectins.
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):2837-2842
Ludwig AK, Michalak M, Xiao Q, Gilles U, Medrano FJ, Ma H, FitzGerald FG, Hasley WD, Melendez-Davila A, Liu M, Rahimi K, Kostina NY, Rodriguez-Emmenegger C, Möller M, Lindner I, Kaltner H, Cudic M, Reusch D, Kopitz J, Romero A, Oscarson S, Klein ML, Gabius HJ, Percec V
Targeting cancer-specific glycans by cyclic peptide lectinomimics.
Amino Acids. 2017 Nov;49(11):1867-1883
Rodriguez MC, Yongye AB, Cudic M, Martinez Mayorga K, Liu E, Mueller BM, Ainsley J, Karabencheva-Christova T, Christov CZ, Cudic M, Cudic P
Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate.
Sci Rep. 2016 Dec 05;6(1):11
Madoux F, Dreymuller D, Pettiloud JP, Santos R, Becker-Pauly C, Ludwig A, Fields GB, Bannister T, Spicer TP, Cudic M, Scampavia LD, Minond D
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential.
Sci Rep. 2016 08 22;6:31740
Lohmueller JJ, Sato S, Popova L, Chu IM, Tucker MA, Barberena R, Innocenti GM, Cudic M, Ham JD, Cheung WC, Polakiewicz RD, Finn OJ
Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.
Biochemistry. 2015 Jul 28;54(29):4462-74
Rodriguez MC, Yegorova S, Pitteloud JP, Chavaroche AE, André S, Ardá A, Minond D, Jiménez-Barbero J, Gabius HJ, Cudic M
Evaluation of a triple-helical peptide with quenched FluorSophores for optical imaging of MMP-2 and MMP-9 proteolytic activity.
Molecules. 2014 Jun 23;19(6):8571-88
Zhang X, Bresee J, Cheney PP, Xu B, Bhowmick M, Cudic M, Fields GB, Edwards WB
Glycosylation modulates melanoma cell α2β1 and α3β1 integrin interactions with type IV collagen.
J Biol Chem. 2014 Aug 01;289(31):21591-604
Stawikowski MJ, Aukszi B, Stawikowska R, Cudic M, Fields GB
Glycosylation of a disintegrin and metalloprotease 17 affects its activity and inhibition.
Anal Biochem. 2014 Mar 15;449:68-75
Chavaroche A, Cudic M, Giulianotti M, Houghten RA, Fields GB, Minond D
Optimization of physicochemical and pharmacological properties of peptide drugs by glycosylation.
Methods Mol Biol. 2013;1081:107-36
Rodriguez MC, Cudic M
Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.
J Biol Chem. 2013 Aug 02;288(31):22871-9
Stawikowska R, Cudic M, Giulianotti M, Houghten RA, Fields GB, Minond D